We are live on ! Find out more
GENE

Genetic Technologies Ltd.
GENE

Delisted

GENE was delisted on the 16th of October, 2024.

Back to rankings

10 hedge funds and large institutions have $1.06M invested in Genetic Technologies Ltd. in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

25% more funds holding

Funds holding: 8 → 10 (+2)

64% less capital invested

Capital invested by funds: $2.98M → $1.06M (-$1.92M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 6

Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
+$20.9K
2
Creative Planning
Creative Planning
Kansas
+$20.4K
3
Citigroup
Citigroup
New York
+$107

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$609K
2
VKH
Virtu KCG Holdings
New York
-$225K
3
Millennium Management
Millennium Management
New York
-$208K
4
TRCT
Tower Research Capital (TRC)
New York
-$46.8K
5
Citadel Advisors
Citadel Advisors
Florida
-$4.29K

GENE Hedge Fund Activity: Q3 2015 in Review

10 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q3 2015, worth a combined $1.06M — down 64% from $2.98M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new GENE positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 6 trimmed.

The largest buyer was Deutsche Bank, opening a new position worth an estimated $20.9K. The largest seller was Renaissance Technologies, cutting an estimated $609K.

  • 10 institutional investors held Genetic Technologies Ltd. (GENE) as of Q3 2015, up from 8 in Q2 2015.
  • Funds reported $1.06M of Genetic Technologies Ltd. stock for Q3 2015, down 64% quarter-over-quarter.
  • 3 funds opened new Genetic Technologies Ltd. positions in Q3 2015 and 1 closed out, a net change of +2 holders.
  • The largest Genetic Technologies Ltd. buyer in Q3 2015 was Deutsche Bank, an estimated $20.9K added.
  • The largest Genetic Technologies Ltd. seller in Q3 2015 was Renaissance Technologies, an estimated $609K sold.

Based on aggregated 13F filings for Q3 2015.